While the first observations on the anti-tubercular activity of hydrazine derivatives of isonicotinic acid5'6 were made using the experimental infection of mice with Mycobacterium tuberculosis var. hominis, it has become evident through the work of Bernstein, Lott, Steinberg, and Yale' and Steenken and Wolinsky11 that the bovine type of M. tuberculosis was also markedly sensitive to the new chemotherapeutic agents. The experiments with this organism that are being reported here supplement the work of Bernstein, et al.' inasmuch as the observation time was extended in an attempt to determine the duration of the protective effect brought about by the administration of the new compounds. Moreover, the lungs of the animals used in these experiments were examined and the bacteriological effect of the treatment was evaluated by culture. The observations made in this study are discussed in the present paper.
In vivo experiments. As representative compounds to show the effect of the hydrazine derivatives of isonicotinic acid, Rimifon* and its isopropyl derivative Marsilid were selected. In some experiments, a third hydrazine derivative, namely, 1-isonicotinyl-2-d-glucosyl-hydrazine was included. The effect of this atoxic glucosyl derivative (LDcso for mice = greater than 2500 mg./kg. subcutaneously; 1750 mg./kg. by gavage) has been described by Zieper and Lewis' who employed this substance in a tuberculous monkey. Its activity in mice infected with the bovine strain of M. tuberculosis has also been studied in the experiments reported by Bernstein, et al.'
For reasons of comparison compounds of known anti-tubercular activity such as streptomycin, nicotinamide,9 nicotinaldehyde thiosemicarbazone,"7 and isonicotinaldehyde thiosemicarbazone"8 were also included.
Protective experiments with a treatment period of 21 days and an observation period of an additional 21 days. In this group of experiments the intravenously infected mice were kept on a medicated diet for 21 days and then observed for an additional 21 days during which time they received a normal diet of Borden's Chunx. The hydrazine derivatives as well as streptomycin were tested at two dosage levels. The study with the two thiosemicarbazones was limited to the higher dose since previous experience had shown that no lasting effect could be expected in this series of compounds.! The results of the experiments are given in Table 1. This  table does not contain information about the survival time, because all animals treated with the different drugs were still alive at the end of the 42-day observation period. The controls, on the other hand, had the usual average survival time of 22.1 days.
The data in Table 1 , however, indicate that evaluation on the basis of survival time only, without post-mortem examination, does not give a true picture of the type of activity encountered in investigations of the antitubercular activity of new compounds. The column "average extent of lesions" which is based on the gross examination of the lungs clearly shows that at the end of the 21-day observation period following 21 days' treatment, anti-tubercular agents such as Rimifon and Marsilid still exerted a marked inhibition on the development of gross pulmonary lesions. This effect was found to be dependent on the dose inasmuch as the lower dose of 25.0 mg./kg./day allowed the development of somewhat more extensive pulmonary involvement. The other agents included in this series of experiments appeared considerably less active, particularly streptomycin. The lesions in the mice receiving streptomycin were as marked as those of the controls.
The thiosemicarbazones of nicotinaldehyde and isonicotinaldehyde appeared also inferior to the hydrazine derivatives of isonicotinic acid which is in agreement with earlier results. ' As a rule, the histological examination of the tissues reflected the gross findings inasmuch as the exudative lesions which dominate the microscopical appearance of the pulmonary tuberculosis of mice were considera- bly less marked in organs of animals treated with the hydrazine derivatives of isonicotinic acid. Complete lobular consolidation and even more extensive confluent lesions as observed in controls or unsuccessfully treated animals were absent in the protected mice, although very small scattered infiltrations were occasionally seen even in the lungs which appeared normal at gross examination. Under these circumstances the results of the cultural examinations of the lungs seem to be of particular interest. The figures in the last column of Table 1 clearly demonstrate the fact that the hydrazine derivatives of isonicotinic acid and only these agents were able to prevent in a substantial number of animals the growth of M. tuberculosis in cultures taken 21 days after discontinuance of treatment. The only anti-tubercular agent even approaching a similar effect is streptomycin if given in a high dose. It seems appropriate, however, to point out that the absence of growth by direct culturing of lung tissue may not represent a sufficiently sensitive method to allow any claims as to sterilization of the lung tissue by chemotherapy with the hydrazine derivatives of isonicotinic acid. As in our earlier observations of a similar nature' we can only claim that sufficient damage has been done to the organisms or their number so substantially reduced that recovery is no longer possible by cultural means. Protective experiments with a treatment period of 28 days and an observation period of an additional 72 days. Since the experiments described in the first section of this paper did not show a characteristic endpoint of survival time, two groups of experiments were carried out in which the total observation time was extended to 100 days. The treatment period in these experiments was extended to 28 days instead of 21 days which leaves a lapse of 72 days between the termination of therapy and the final evaluation of the degree of protection.
In one of these experiments the usual intravenous infective dose of 0.5 ml. of a 101 dilution of a 7-to 10-day-old culture as employed in the earlier experiments was used. The results of these observations are given in at a high dosage level of 150 mg./kg./day, was inferior to the hydrazine derivatives of isonicotinic acid. Nicotinamide failed to show any degree of protection although it always has a demonstrable effect in the infection with the human strain of M. tuberculosis."9 All surviving animals exhibited at gross as well as at microscopic examination lesions whose extent was, however, markedly reduced in all animals receiving Rimifon. A reduction of lesions was observed with the glucosyl derivative of Rimifon only at the high dosage level. Demonstration of tubercle bacilli in the sections of the lungs of these mice also showed that only a few scattered acid-fast organisms could be observed, while the lesions of the controls and unsuccessfully treated animals contained numerous bacilli in dense clusters.
In a second experiment presented in Table 3 a heavier infection was given, namely, 0.5 ml. of an undiluted culture, 7 to 10 days old, intravenously. Almost identical results were obtained as in the experiments just described. The length of the average survival time as well as the number of animals surviving the entire period of observation was again most marked in case of Rimifon. Its glucosyl derivative appeared less active even at the high dosage level of 250 mg./kg./day. At the lower dose level, not only was the prolongation of life markedly reduced, but no final survivors were observed. Streptomycin in both dosages exhibited its well-known delay of death, but the number of final survivors was negligible. Nicotinamide, despite a high dose of 2500 mg./kg./day, was without effect in that the mice succumbed at about the same time as the controls.
Cultures, which were only taken from surviving animals, further emphasize the point that results based on survival time alone do not necessarily indicate the complete picture of anti-tubercular activity of closely related compounds. In the case of Rimifon an appreciable number of negative cultures were obtained from surviving animals, while with its glucosyl derivative growth of M. tuberculosis was observed in the majority of the cultures taken from the lungs.
DISCUSSION
The data given in the experimental part of this paper confirm the value of the method of the fatal infection of mice with the Ravenel strain of M. tuberculosis var. bovis for the evaluation of the anti-tubercular activity of chemotherapeutic agents. The results also confirm the work of Bernstein, et al.2 with the hydrazine derivatives of isonicotinic acid. Principally, the results obtained in these experiments with the Ravenel strain of M. tuberculosis var. bovis corroborate those described in earlier publications"' for M. tuberculosis H37Rv. Rimifon and Marsilid as the representative compounds of the hydrazine derivatives of isonicotinic acid not only considerably extended the survival time of the treated animals, but also produced almost the same reduction in the extent of lesions as described in experiments with M. tuberculosis var. hominis. Furthermore, the marked influence on the viability of M. tuberculosis var. hominis could also be demonstrated with the bovine type of M. tuberculosis even 72 days after discontinuation of treatment.
The entirety of these findings suggests that the determination of limited survival time as recommended by some authorse3 does not always allow the necessary differentiation between chemically related compounds of different degrees of activity. The glucosyl derivative of Rimifon which appears under certain conditions equivalent to the parent substance can be shown to be inferior to Rimifon by the use of lower dosage ranges, by extended observation time, and by cultural means. In addition, the undoubtedly marked effect of streptomycin on the survival time loses its significance if one considers the number of final survivors at the end of the extended survival time and the presence of specific lesions. At the present time only Rimifon and the related Marsilid seem to satisfy the requirement for anti-tubercular drugs which produce lasting protection apparently by their direct effect on the viability of the causative organisms. 2. Additional evidence is presented to show that the new agents, e.g. Rimifon and Marsilid, exerted the same type of activity on the bovine type of strain as was earlier reported for infections with M. tuberculosis var. hominis. The oral administration of the compounds resulted in considerably prolonged survival time, absence or reduction of tuberculous lesions in the lungs, and prevention of growth of tubercle bacilli in cultures taken from the lungs.
3. The demonstration of these properties of the hydrazine derivatives of isonicotinic acid establishes their superiority to known anti-tubercular drugs and also allows the evaluation of the therapeutic potency of chemically closely related products.
